Early onset of treatment effects with oral risperidone

BMC Psychiatry

Volumn 7, Issue , 2007, Pages

  Raedler, Thomas J ^a   Schreiner, Andreas ^b   Naber, Dieter ^a   Wiedemann, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Janssen Cilag ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; DIAZEPAM; LORAZEPAM; NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HOSPITAL ADMISSION; HUMAN; MEDICAL RESEARCH; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTIPSYCHOTIC AGENTS; HUMANS; RISPERIDONE; SCHIZOPHRENIA; TIME FACTORS;

EID: 33846805695     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-7-4     Document Type: Article

References (10)

1. Agid O Kapur S Arenovich T Zipursky RB Delayed-onset hypothesis of antipsychotic action: A hypothesis tested and rejected Arch Gen Psychiatry 2003 60 1228-1235 10.1001/archpsyc.60.12.1228 14662555
2. Leucht S Busch R Hamann J Kissling W Kane JM Early-onset hypothesis of antipsychotic drug action: A hypothesis tested, confirmed and extended Biol Psychiatry 2005 57 1543-1549 10.1016/j.biopsych.2005.02.023 15953491
3. Raedler TJ Schreiner A Naber D Wiedemann K Risperidone in the treatment of acute schizophrenia J Clin Psychopharmacol 2004 24 335-338 10.1097/ 01.jcp.0000126660.50788.ef 15118488
4. Rojo JE Gibert K Cobo J Rodriguez-Cano E Vallejo J Onset of antidepressant action: A pharmacological question? Hum Psychopharmacol 2005 20 425-433 10.1002/hup.708 16106477
5. Mitchell AJ Two-week delay in onset of action of antidepressants: New evidence Br J Psychiatry 2006 188 105-106 10.1192/bjp.bp.105.011692 16449694
6. Kapur S Arenovich T Agid O Zipursky R Lindborg S Jones B Evidence for onset of antipsychotic effects within the first 24 hours of treatment Am J Psychiatry 2005 162 939-946 10.1176/appi.ajp.162.5.939 15863796
7. Small JG Kolar MC Kellams JJ Quetiapine in schizophrenia: Onset of action within the first week of treatment Curr Med Res Opin 2004 20 1017-1023 10.1185/030079904125004033 15265246
8. Möller HJ Bäuml J Ferrero F Fuger J Geretsegger C Kasper S Kissling W Schubert H Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland Eur Arch Psychiatry Clin Neurosci 1997 247 291-296 9477007
9. Bondolfi G Dufour H Patris M May JP Billeter U Eap CB Baumann P Risperidone versus clozapine in treatment-resistant chronic schizophrenia: A randomized double-blind study. The Risperidone Study Group Am J Psychiatry 1998 155 499-504 9545995
10. Huttunen MO Piepponen T Rantanen H Larmo I Nyholm R Raitasuo V Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: A double-blind parallel-group trial Acta Psychiatr Scand 1995 91 271-277 7542829